Keynote Speakers
View All Speakers-
Malcolm Wilson The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester
Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours
-
Professor Jayant Vaidya University College London
Targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer
-
Dr Abeer Shaaban Queen Elizabeth Hospital Birmingham & University of Birmingham
Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations
-
Lucinda Billingham University of Birmingham - Cancer Research Clinical Trials Unit
National Lung Matrix Trial: testing multiple novel targeted treatments
-
Mr Hamish Clouston The Christie NHS Foundation Trust
Surgical Management of Advanced Colonic and Rectal Malignancies.
-
Professor Anthony Howell The University of Manchester / The Christie NHS Foundation Trust
Improving risk estimation of breast cancer
-
Dr Natalie Cook University of Manchester/Christie NHS Foundation Trust
Molecular testing and novel therapies in prostate cancer
-
Dr Khurum Khan University College London Hospitals
Translational research in GI Oncology- how to make progress?
-
Dr Catherine Coyle Christie Hospital NHS Foundation Trust
Prostate Cancer- the non surgical oncologists view
-
Professor Noel Clarke The Christie and Salford Royal Hospitals, Manchester UK
Improving Prostate Cancer Outcomes Through Cancer Trials
Suppliers
View More
2cureX
Stand No: 750
Vision RT
Stand No: 724
Medical Protection Society
Stand No: 756
Throat Cancer Foundation
Stand No: 800
Aderans UK Ltd. (Trendco)
Stand No: 768
Scandinavian ChemoTech AB
Stand No: 676
PathCloud
Stand No:
facefacts Int Ltd
Stand No: 788
News And Blogs
View More
Breast cancer : the worrying statistics
Breast cancer. It’s the most common and aggressive cancer in the...
HPV vaccine for males shows positive signs of prevention
The prevention of disease is an integral focus of the European...
Northumbria Healthcare NHS Foundation Trust in landmark partnership with Rutherford Cancer Centre
The Rutherford Cancer Centre North East and Northumbria Healthcare has announced...
The creative future of cancer treatment
‘’MIT biologists have now found that by combining two existing classes...
Advances & obstacles in oncology
The Oncology industry is right at the forefront of pioneering new...
